Moonlake immunotherapeutics MLTX.US Value Analysis
US StockHealth Care
(No presentation for MLTX)
MLTX Value Score
3
24
15
Poor Growth
- AI analysis rates MLTX with the lowest value score of 1.
- It is mainly due to unstable operating cash flow, along with potential value may be lower.
- Over the past 3 months, MLTX has maintained a consecutive value rating of 1.0, close to the rating of 0.8 over the past 3 years, indicating low growth opportunities for enterprise value.
- Compared to all stocks in the Health Care sector, MLTX has a lower value rating.
MLTX Value Reference Factors
The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.
No related data records
Update to 2025/03/01 (Weekly Update)
MLTX Financial Forecast
Unit : USD
Update to 2025/5/4 (Quarterly Update)
MLTX Earnings Table
No related data records
MLTX Historical Value Score
You can use historical scores of 3 or above to observe potential performance and make investment decisions.
MLTX Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of MLTX from 2020/12 till Now
- -
- Cumulative Return
- -
- Annual Return
- -
- Volatility
- -
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from December, 2020 to May, 2025. (Total Trades: 0)
| MLTX | Sector | US Overall Market | |
|---|---|---|---|
| Wining Rate | - | 44% | 53% |
| Avg Return | - | 63.1% | 72.3% |
| Avg Profit | - | 198.4% | 166.4% |
| Avg Loss | - | -44.8% | -34.6% |
| Avg Risk-Reward Ratio | - | 442.5% | 480.4% |
Update to 2025/5/8 (Daily Update)